Advancements and Challenges in Transcatheter Aortic Valve Replacement (TAVR)
A special issue of Prosthesis (ISSN 2673-1592).
Deadline for manuscript submissions: 31 October 2024 | Viewed by 204
Special Issue Editors
Interests: cardiovascular disease; vascular surgery; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: coronary artery disease; valve disease; mechanical circulatory assistance; minimally invasive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The treatment of aortic stenosis has been improved through transcatheter aortic valve replacement (TAVR). At the beginning, TAVR was only performed in patients at high surgical risk. However, with the accumulation of evidence and the expansion of indications, TAVR is now performed and approved for patients at all risk levels. The developments in valve technology and delivery systems have been rapid, with a concomitant reduction in the complication profile, particularly vascular complications. However, as TAVR continues to advance, several important challenges remain. This review summarizes the historical developments leading to modern TAVR practices and discusses their future trajectory.
This Special Issue will investigate current TAVR practices and discuss future directions. This is a great opportunity to provide a guide to physicians and to offer them a general understanding of the most important issues in this field.
Prof. Dr. Raffaele Serra
Prof. Dr. Giuseppe Filiberto Serraino
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Prosthesis is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transcatheter aortic valve replacement (TAVR)
- surgical aortic valve replacement (SAVR)
- aortic stenosis
- valvular heart disease
